- Home
- BOTJ vs SNTI Comparison
BOTJ vs SNTI Comparison
Compare BOTJ & SNTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOTJ
- SNTI
- Stock Information
- Founded
- BOTJ 1998
- SNTI 2016
- Country
- BOTJ United States
- SNTI United States
- Employees
- BOTJ N/A
- SNTI 48
- Industry
- BOTJ Major Banks
- SNTI Biotechnology: Pharmaceutical Preparations
- Sector
- BOTJ Finance
- SNTI Health Care
- Exchange
- BOTJ Nasdaq
- SNTI Nasdaq
- Market Cap
- BOTJ 62.6M
- SNTI 50.3M
- IPO Year
- BOTJ N/A
- SNTI N/A
- Fundamental
- Price
- BOTJ $13.76
- SNTI $1.93
- Analyst Decision
- BOTJ
- SNTI Strong Buy
- Analyst Count
- BOTJ 0
- SNTI 2
- Target Price
- BOTJ N/A
- SNTI $8.50
- AVG Volume (30 Days)
- BOTJ 2.6K
- SNTI 514.4K
- Earning Date
- BOTJ 08-05-2025
- SNTI 08-12-2025
- Dividend Yield
- BOTJ 2.91%
- SNTI N/A
- EPS Growth
- BOTJ N/A
- SNTI N/A
- EPS
- BOTJ 1.45
- SNTI N/A
- Revenue
- BOTJ $45,083,000.00
- SNTI N/A
- Revenue This Year
- BOTJ N/A
- SNTI N/A
- Revenue Next Year
- BOTJ N/A
- SNTI $150.00
- P/E Ratio
- BOTJ $9.48
- SNTI N/A
- Revenue Growth
- BOTJ 4.72
- SNTI N/A
- 52 Week Low
- BOTJ $11.56
- SNTI $1.52
- 52 Week High
- BOTJ $17.05
- SNTI $16.94
- Technical
- Relative Strength Index (RSI)
- BOTJ 43.25
- SNTI 37.06
- Support Level
- BOTJ $13.30
- SNTI $1.86
- Resistance Level
- BOTJ $13.95
- SNTI $2.12
- Average True Range (ATR)
- BOTJ 0.23
- SNTI 0.16
- MACD
- BOTJ -0.02
- SNTI 0.03
- Stochastic Oscillator
- BOTJ 48.52
- SNTI 24.24
About BOTJ Bank of the James Financial Group Inc.
Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments community banking; mortgage banking, and investment advisory services.
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.